Fulminant Immune Checkpoint Inhibitor-Induced Myocarditis and Complete Heart Block in Advanced Melanoma: A Case Report. [PDF]
Alhayek B +4 more
europepmc +1 more source
Utilization of Proteomic Measures for Early Detection of Drug Benefits and Adverse Effects. [PDF]
Chadwick J +17 more
europepmc +1 more source
Loss-of-function of lipopolysaccharide-responsive beige-like anchor protein causes inflammatory bowel disease-a case report and literature review. [PDF]
Wang Z, Fang Y, Yu J, Chen J, Luo Y.
europepmc +1 more source
Vaccination Update and Specific Concerns for RA. [PDF]
Urquiaga M, Winthrop KL, Curtis JR.
europepmc +1 more source
Beyond Monotherapy: Exploring the Efficacy and Safety of Dual Biologic Strategies in Rheumatic Diseases. [PDF]
Hassan F, Jeries H, Daood R, Naffaa ME.
europepmc +1 more source
Type 1 Diabetes TrialNet: Leading the Charge in Disease Prediction, Prevention, and Immunotherapeutic Mechanistic Understanding. [PDF]
Jacobsen LM +5 more
europepmc +1 more source
A novel <i>CTLA-4</i> deletion variant in a child with refractory autoimmune hemolytic anemia: molecular and functional characterization. [PDF]
Chen F +6 more
europepmc +1 more source
Latest Updates in Prevention and Screening of Type 1 Diabetes Mellitus. [PDF]
Citron-Zafrin K, Gandica R, Leibel N.
europepmc +1 more source
Exploring drug-induced pemphigus findings from the FDA adverse event reporting system database. [PDF]
Niu Y, Lu H, He L, Wang Z, Duan X.
europepmc +1 more source

